Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement

Author:

Merriel Samuel W.D.1ORCID,Hetherington Liz2,Seggie Andrew3,Castle Joanna T.3,Cross William4,Roobol Monique J.5ORCID,Gnanapragasam Vincent6ORCID,Moore Caroline M.7ORCID,

Affiliation:

1. Exeter Medical School; University of Exeter; Exeter UK

2. Independent Qualitative Researcher; London UK

3. Prostate Cancer UK; London UK

4. St James University Hospital; Leeds UK

5. Department of Urology; Erasmus University Medical Centre; Rotterdam The Netherlands

6. Department of Surgery; University of Cambridge; Cambridge UK

7. Division of Surgery and Interventional Science; University College London; London UK

Funder

Prostate Cancer UK

Publisher

Wiley

Subject

Urology

Reference34 articles.

1. Ferlay J Soerjomataram I Ervik M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] 2013 http://globocan.iarc.fr

2. Overdiagnosis of prostate cancer;Sandhu;J Natl Cancer Inst,2012

3. Active Surveillance in men with localized prostate cancer;Dahabreh;Ann Intern Med,2012

4. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer;Hamdy;N Engl J Med,2016

5. Radical prostatectomy versus observation for localized prostate cancer;Wilt;N Engl J Med,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3